Incannex Healthcare - $IXHL - Ep:040

https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/3f/aa/2c/3faa2c38-1689-c3e0-7246-364d8d9a093c/mza_8000196554104980122.jpg/600x600bb.jpg

Nano Cap Podcast

Will Tjernlund

48 episodes

2 days ago

On the Nano Cap Podcast, we dive into the unique world of publicly traded companies with a market capitalization under $50 million – the nano caps. These are not just numbers on a stock ticker; they are stories of ambition, struggle, and triumph. Each episode, I'll sit down with the leaders and visionaries behind these companies. We’ll uncover the challenges they face, the innovations they bring, and the strategies that drive them forward in a competitive market.

Investing

Business

RSS

All content for Nano Cap Podcast is the property of Will Tjernlund and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Investing

Business

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/40221642/40221642-1750081159210-472882935365.jpg

Incannex Healthcare - $IXHL - Ep:040 - Nano Cap Podcast

Nano Cap Podcast

23 minutes 30 seconds

5 months ago

Incannex Healthcare - $IXHL - Ep:040 - Nano Cap Podcast

In this Episode, Joel Latham, CEO of Incannex Healthcare, discusses his career journey, the innovative approaches of Incannex Healthcare in drug development, particularly focusing on combination therapies involving cannabinoids and psychedelics. He highlights the company's unique solutions for obstructive sleep apnea and other chronic conditions, emphasizing the importance of patient-centric approaches and the potential for significant market impact. Latham also shares insights into the future vision of Incannex Healthcare and the expected advancements in their lead assets.

INCANNEX WEBSITE:

https://incannex.com/

NANO CAP PODCAST WEBSITE: https://www.nanocappod.com/

DISCLAIMER - The contents of this podcast are for informational purposes only and do not constitute financial, investment, legal, or other professional advice. Listeners should not construe any information discussed as a recommendation to buy, sell, or hold any securities or investments. Always consult with a qualified financial advisor or professional before making any financial decisions.